Provided by Tiger Trade Technology Pte. Ltd.

Armata Pharmaceuticals, Inc.

7.70
-0.3800-4.70%
Post-market: 7.700.00000.00%19:45 EST
Volume:36.72K
Turnover:290.81K
Market Cap:280.33M
PE:-5.98
High:8.11
Open:8.11
Low:7.70
Close:8.08
52wk High:16.34
52wk Low:0.8981
Shares:36.41M
Float Shares:10.87M
Volume Ratio:0.65
T/O Rate:0.34%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2882
EPS(LYR):-0.8886
ROE:-3439.35%
ROA:-22.20%
PB:-2.93
PE(LYR):-8.67

Loading ...

Armata Pharmaceuticals Inc - Amends Four Existing Credit Agreements - SEC Filing

THOMSON REUTERS
·
Jan 26

Armata Pharmaceuticals Extends Loan Maturities With Innoviva to 2027

Reuters
·
Jan 26

Rpt-Armata Pharmaceuticals Inc: FDA Agreed That Data From Phase 2a Disarm Study Support Advancement of AP-Sa02 to a Phase 3 Study

THOMSON REUTERS
·
Jan 13

Armata Advances Phage Therapy Candidate AP-SA02 to Phase 3 After Positive FDA Review

Reuters
·
Jan 13

Armata Pharmaceuticals Inc: Phase 3 Study Is Anticipated to Initiate in Second Half of 2026.

THOMSON REUTERS
·
Jan 13

Armata Pharmaceuticals Announces End-of-Phase 2 Meeting With FDA and Plans to Advance AP-Sa02 to a Phase 3 Superiority Study in Complicated Bacteremiastaphylococcusaureus

THOMSON REUTERS
·
Jan 13

Armata Pharmaceuticals Initiated at Buy by Jones Trading

Dow Jones
·
Jan 06

Armata Pharmaceuticals Inc : Jonestrading Initiates Coverage With Buy Rating; Target Price $15

THOMSON REUTERS
·
Jan 05

Armata Pharmaceuticals Reports Positive Phase 2a Results for AP-SA02 in Staph Aureus Bacteremia

Reuters
·
Nov 18, 2025

Armata Pharmaceuticals reports third quarter loss from operations of $7.8 million

Reuters
·
Nov 13, 2025

Armata Pharmaceuticals Secures $15 Million Loan from Innoviva Strategic Opportunities

Reuters
·
Nov 13, 2025

Armata Pharmaceuticals Announces Third Quarter 2025 Results and Provides Corporate Update

THOMSON REUTERS
·
Nov 13, 2025

Armata Pharmaceuticals Commissions Manufacturing Facility in Los Angeles

MT Newswires Live
·
Nov 10, 2025

Armata Pharmaceuticals trading resumes

TIPRANKS
·
Nov 10, 2025

Amex Halt Add Info Lst 5.810000

THOMSON REUTERS
·
Nov 10, 2025

BRIEF-Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles

Reuters
·
Nov 10, 2025

Armata Pharmaceuticals Inc - FDA Notified of Production Commencement; No Issues Reported

THOMSON REUTERS
·
Nov 10, 2025

Health Rounds: Viruses may hold key to tackling deadly bacterial infection

Reuters
·
Oct 31, 2025

Amex Halt Add Info Lst 7.930000

THOMSON REUTERS
·
Oct 23, 2025

Amex Halt Add Info Lst 13.370000

THOMSON REUTERS
·
Oct 23, 2025